Sharon J. Feng

CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway

Jacob E. Corn, J. Corn, E. Zelin, 2018, Nature Genetics.

Development and clinical validation of a targeted RNAseq panel (Fusion-STAMP) for diagnostic and predictive gene fusion detection in solid tumors

Helio A. Costa, C. Bustamante, E. Fung, 2019, bioRxiv.

A multiplexed transcription activator-like effector system for detecting specific DNA sequences.

M. Arcellana‐Panlilio, Christopher M. Wintersinger, Himika Dastidar, 2014, ACS synthetic biology.

Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair

S. Wyman, A. Marson, J. Corn, 2018, bioRxiv.

CRISPR-Cas9 genome editing in human cells works via the Fanconi Anemia pathway

J. Corn, S. Floor, Katelynn R. Kazane, 2017, bioRxiv.

CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway

J. Corn, E. Zelin, S. Floor, 2018, Nature Genetics.